The FDA approves Vertex's non-opioid oral pain signal inhibitor, Journavx, for treating adults with moderate-to-severe acute pain. Shares rise.

The following is a summary of “Feasibility of trancutaneous auricular vagus nerve stimulation in Black and Hispanic/Latino people with peripheral neuropathy,” published in the January 2025 issue of ...

The US Food and Drug Administration (FDA) has approved Vertex Pharmaceuticals’ oral Journavx (suzetrigine) to treat adults ...

GP Dr Roger Henderson provides an overview of the chronic complications of diabetes and the key preventive measures ...

The following is a summary of “Correlation between high-sensitivity cardiac troponin levels in diabetic patients’ serum and ...

SLEEP is essential for good health and well-being. It keeps heart health in check, helps you maintain a healthy weight, makes ...

Leerink Partners analyst David Risinger has reiterated their bullish stance on VRTX stock, giving a Buy rating yesterday.Invest with ...

Dr. Lucas Brown, DAOM, LAc, spoke with Studio 512 about how his clinic, Rosedale Acupuncture & Wellness, can help with chronic pain conditions, including peripheral neuropathy. You treat ...

Dr Amir Khan, who is a GP and works on TV shows including Lorraine and Good Morning Britain, has taken to social media to share five early signs you might have type 2 diabetes ...

Medically reviewed by Adam H. Kaplan, DPM Foot problems run the gamut from blisters caused by wearing the wrong shoes to nonhealing foot ulcers caused by diabetes. Some foot problems are triggered by ...

Hybrid closed-loop insulin therapy was associated with a higher risk for diabetic ketoacidosis but a lower risk for hypoglycemic coma than open-loop therapy in T1D. Use of a hybrid closed-loop insulin ...

Length-dependent diabetic polyneuropathy does not show any trend towards improvement, and either relentlessly progresses or remains relatively stable over a number of years. Conversely ...